Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

434 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
Tsukamoto T, Yuasa M, Yamamoto H, Kawada M, Takeda A, Igarashi H, Matano T. Tsukamoto T, et al. Among authors: yuasa m. J Virol. 2007 Nov;81(21):11640-9. doi: 10.1128/JVI.01475-07. Epub 2007 Aug 29. J Virol. 2007. PMID: 17728225 Free PMC article.
Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M, Araoka H, Yoshida A, Yamamoto H, Abe M, Okamoto Y, Yuasa M, Kaji D, Kageyama K, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Uchida N, Hishinuma A, Izutsu K, Wake A, Taniguchi S, Yoneyama A. Kimura M, et al. Among authors: yuasa m. BMC Infect Dis. 2016 Aug 5;16:372. doi: 10.1186/s12879-016-1692-y. BMC Infect Dis. 2016. PMID: 27495798 Free PMC article.
Predictive scoring system for distinguishing Stenotrophomonas maltophilia bacteremia from Pseudomonas aeruginosa bacteremia in patients with hematological malignancies.
Sakoh T, Kimura M, Takagi S, Ogura S, Morishima M, Yamamuro R, Yamaguchi K, Yuasa M, Kaji D, Kageyama K, Taya Y, Nishida A, Ishiwata K, Yamamoto H, Yamamoto G, Asano-Mori Y, Wake A, Uchida N, Taniguchi S, Araoka H. Sakoh T, et al. Among authors: yuasa m. Ann Hematol. 2023 May;102(5):1239-1246. doi: 10.1007/s00277-023-05185-7. Epub 2023 Mar 27. Ann Hematol. 2023. PMID: 36971808 Clinical Trial.
Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
Ogura S, Kimura M, Takagi S, Mitsuki T, Yuasa M, Kageyama K, Kaji D, Nishida A, Taya Y, Ishiwata K, Yamamoto H, Asano-Mori Y, Yamamoto G, Uchida N, Wake A, Taniguchi S, Araoka H. Ogura S, et al. Among authors: yuasa m. Eur J Clin Microbiol Infect Dis. 2021 May;40(5):941-948. doi: 10.1007/s10096-020-04096-z. Epub 2020 Nov 13. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33185742
A Novel Reduced-Toxicity Myeloablative Conditioning Regimen Using Full-Dose Busulfan, Fludarabine, and Melphalan for Single Cord Blood Transplantation Provides Durable Engraftment and Remission in Nonremission Myeloid Malignancies.
Yamamoto H, Uchida N, Yuasa M, Kageyama K, Ota H, Kaji D, Nishida A, Ishiwata K, Takagi S, Tsuji M, Asano-Mori Y, Yamamoto G, Izutsu K, Masuoka K, Wake A, Yoneyama A, Makino S, Taniguchi S. Yamamoto H, et al. Among authors: yuasa m. Biol Blood Marrow Transplant. 2016 Oct;22(10):1844-1850. doi: 10.1016/j.bbmt.2016.06.017. Epub 2016 Jun 21. Biol Blood Marrow Transplant. 2016. PMID: 27345142 Free article.
The Long-term Outcomes after VAD plus SCT Therapy in a Patient with AL Amyloidosis and Severe Factor X Deficiency.
Iwadate D, Hasegawa E, Hoshino J, Hayami N, Sumida K, Yamanouchi M, Sekine A, Kawada M, Hiramatsu R, Suwabe T, Sawa N, Yuasa M, Wake A, Fujii T, Ohashi K, Takaichi K, Ubara Y. Iwadate D, et al. Among authors: yuasa m. Intern Med. 2018 Mar 1;57(5):701-706. doi: 10.2169/internalmedicine.9263-17. Epub 2017 Nov 1. Intern Med. 2018. PMID: 29093408 Free PMC article.
Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
Kimura M, Araoka H, Yamamoto H, Nakamura S, Nagi M, Yamagoe S, Miyazaki Y, Ogura S, Mitsuki T, Yuasa M, Kaji D, Kageyama K, Nishida A, Taya Y, Shimazu H, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Uchida N, Wake A, Taniguchi S, Yoneyama A. Kimura M, et al. Among authors: yuasa m. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e02183-17. doi: 10.1128/AAC.02183-17. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29530846 Free PMC article.
No post-transplant pure red cell aplasia development in 106 major ABO incompatible cord blood transplantation.
Wada S, Asano-Mori Y, Yamamoto H, Yuasa M, Kageyama K, Kaji D, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Uchida N, Yoneyama A, Makino S, Taniguchi S. Wada S, et al. Among authors: yuasa m. Bone Marrow Transplant. 2019 May;54(5):765-768. doi: 10.1038/s41409-018-0375-2. Epub 2018 Nov 6. Bone Marrow Transplant. 2019. PMID: 30401968 Clinical Trial. No abstract available.
Splenomegaly Negatively Impacts Neutrophil Engraftment in Cord Blood Transplantation.
Yuasa M, Yamamoto H, Kageyama K, Kaji D, Taya Y, Takagi S, Yamamoto G, Asano-Mori Y, Wake A, Yoneyama A, Makino S, Uchida N, Taniguchi S. Yuasa M, et al. Biol Blood Marrow Transplant. 2020 Sep;26(9):1689-1696. doi: 10.1016/j.bbmt.2020.05.018. Epub 2020 Jun 4. Biol Blood Marrow Transplant. 2020. PMID: 32505808 Free article.
434 results